Viking Global Opportunities Parent GP LLC's Net Worth

$0

Estimate Recalculated Jul 31, 2025 12:11AM EST

Who is Viking Global Opportunities Parent GP LLC

Viking Global Opportunities Parent GP LLC does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include PROCEPT BioRobotics Corp, Amylyx Pharmaceuticals, Inc., RayzeBio, Inc., 4D Molecular Therapeutics, Inc., Roivant Sciences Ltd., BridgeBio Pharma, Inc., Ginkgo Bioworks Holdings, Inc., Rallybio Corp, Frazier Lifesciences Acquisition Corp, Inhibrx, Inc., APi Group Corp, STANDARD BIOTOOLS INC., and Inhibrx Biosciences, Inc..

SEC CIK

Viking Global Opportunities Parent GP LLC's CIK is 0001886738

Past Insider Trading and Trends

No data available

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Amylyx Pharmaceuticals, Inc.

Investor
Updated Sep 09, 2022
Form 4
-10.26%
-1.40M
$29.80
-$41.72M
Sep 09, 2022
12.24M
Sale
Sep 08 - Sep 09
Form 4
47.22%
2.30M
$19.00
$43.70M
Jan 13, 2022
7.17M
Purchase
Jan 11 - Nov 11
Form 3
Jan 11, 2022
Showing 3 results

RayzeBio, Inc.

Investor
Updated Feb 28, 2024
Form 4
-100.00%
-6.64M
Feb 28, 2024
Disposition
Feb 26
Form 4
-100.00%
-6.64M
Feb 28, 2024
Disposition
Feb 26
Form 4
27.96%
1.45M
$18.00
Sep 21, 2023
6.64M
Purchase
Sep 19
Form 4
27.96%
1.45M
$18.00
Sep 21, 2023
6.64M
Purchase
Sep 19
Form 3
Sep 14, 2023
Form 3
Sep 14, 2023
Showing 6 results

4D Molecular Therapeutics, Inc.

Investor
Updated Jan 05, 2024
Form 4
-11.28%
-540.00K
$19.53
-$10.55M
Jan 05, 2024
4.25M
Sale
Jan 04
Form 4
21.59%
850.00K
$16.00
$13.60M
May 11, 2023
4.79M
Purchase
May 09
Showing 2 results

Roivant Sciences Ltd.

Investor
Updated Jun 26, 2023
Form 4
-14.73%
-13.00M
$9.90
-$128.70M
Jun 26, 2023
75.24M
Sale
Jun 22
Showing 1 results

BridgeBio Pharma, Inc.

Investor
Updated Jul 19, 2023
Form 4
-5.63%
-1.50M
$35.00
-$52.50M
Jul 19, 2023
25.12M
Sale
Jul 18
Showing 1 results

Ginkgo Bioworks Holdings, Inc.

Investor
Updated Mar 04, 2022
Form 4
Mar 04, 2022
339.06M
Acq/Dis
Mar 02
Showing 1 results

Rallybio Corp

Investor
Updated Nov 17, 2022
Form 4
3.33M
$6.00
$20.00M
Nov 17, 2022
3.33M
Purchase
Nov 15
Showing 1 results

Frazier Lifesciences Acquisition Corp

Investor
Updated Nov 25, 2022
Form 4
-100.00%
-3.67M
Nov 25, 2022
Options
Nov 22
Form 4
29.99%
847.06K
$10.08
$8.54M
Nov 04, 2022
3.67M
Purchase
Nov 02
Form 3
Nov 04, 2022
2.82M
Showing 3 results

Inhibrx, Inc.

Investor
Updated Jun 03, 2024
Form 4
-100.00%
-8.19M
$30.00
-$245.69M
Jun 03, 2024
Disposition
May 30
Form 4
1.55M
$19.35
$30.00M
Aug 30, 2023
8.19M
Purchase
Aug 28
Showing 2 results

PROCEPT BioRobotics Corp

Investor
Updated Mar 22, 2022
Form 4
-25.45%
-1.25M
$29.90
-$37.35M
Mar 22, 2022
3.66M
Sale
Mar 18
Showing 1 results

APi Group Corp

Investor
Updated Jun 18, 2024
Form 4
-100.00%
-1.95M
$38.15
-$74.46M
Jun 18, 2024
27.03M
Sale
Jun 17
Form 4
-60.89%
-3.04M
$34.25
-$104.07M
Mar 07, 2024
28.98M
Sale
Mar 05
Form 4
38.93%
3.94M
$30.75
$51.74M
Mar 01, 2024
41.08M
Options
Feb 28
Form 4
-18.90%
-6.50M
$31.30
-$203.45M
Jan 04, 2024
27.89M
Sale
Jan 02
Showing 4 results

STANDARD BIOTOOLS INC.

Investor
Updated Mar 20, 2024
Form 3
Mar 20, 2024
58.65M
Showing 1 results

Inhibrx Biosciences, Inc.

Investor
Updated Jun 07, 2024
Form 3
Jun 07, 2024
1.79M
Showing 1 results